-+ 0.00%
-+ 0.00%
-+ 0.00%

MindMaze Therapeutics Streamlines Organization via Series of Transactions

MT Newswires·08/10/2026 01:41:37
Listen to the news
01:41 AM EDT, 08/10/2026 (MT Newswires) -- MindMaze Therapeutics (MMTX.SW) said Monday it simplified its organization through a series of transactions. As part of the completed initiative, the Swiss neurotherapeutics company divested almost all the remaining non-neurology legacy operations it acquired through its business combination with Relief Therapeutics. The transactions included upfront cash consideration and potential future contingent consideration, with the initiative aimed at simplifying operations, reducing the company's cost base and focusing on its core neurology business.